Dr Marc Oliva is a medical oncologist by training and clinician scientist specialising in head and neck malignancies and early drug development.

Currently, he leads the Head and Neck Cancer Unit and is one of the Principal Investigators of the Drug Development/Phase 1 Unit at Institut Català d’Oncologia, Barcelona, Spain. He is also an associate researcher and principal investigator at Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.